WWA
AGL icon

WC Walker & Associates’s Agilon Health AGL Stock Holding History

WC Walker & Associates’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2,188
Closed -$1.07M – 73
2021
Q4 		$1.07M Buy
+2,188
New +$1.33M 0.53% 39

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

WC Walker & Associates's AGL Position: Q1 2022 in Review

WC Walker & Associates sold out of Agilon Health (AGL) in Q1 2022, closing a stake of 2,188 shares — an estimated $1.07M sold.

WC Walker & Associates first reported a position in AGL in Q4 2021 and held it in 1 quarter. The position peaked at $1.07M in Q4 2021. 121 funds tracked by Wall St. Rank hold AGL as of Q1 2022.

  • WC Walker & Associates reported no remaining Agilon Health position as of Q1 2022 after selling out during the quarter.
  • WC Walker & Associates sold 2,188 Agilon Health shares in Q1 2022, an estimated $1.07M.
  • WC Walker & Associates first reported a position in Agilon Health in Q4 2021 and held it in 1 quarter.
  • WC Walker & Associates's Agilon Health position peaked at $1.07M in Q4 2021.
  • 121 funds tracked by Wall St. Rank held Agilon Health as of Q1 2022.

Based on WC Walker & Associates's 13F filing for Q1 2022, filed 14 Apr 2022.